Inokuchi, R.; Kuno, T.; Komiyama, J.; Uda, K.; Miyamoto, Y.; Taniguchi, Y.; Abe, T.; Ishimaru, M.; Adomi, M.; Tamiya, N.;
et al. Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study. J. Clin. Med. 2022, 11, 116.
https://doi.org/10.3390/jcm11010116
AMA Style
Inokuchi R, Kuno T, Komiyama J, Uda K, Miyamoto Y, Taniguchi Y, Abe T, Ishimaru M, Adomi M, Tamiya N,
et al. Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study. Journal of Clinical Medicine. 2022; 11(1):116.
https://doi.org/10.3390/jcm11010116
Chicago/Turabian Style
Inokuchi, Ryota, Toshiki Kuno, Jun Komiyama, Kazuaki Uda, Yoshihisa Miyamoto, Yuta Taniguchi, Toshikazu Abe, Miho Ishimaru, Motohiko Adomi, Nanako Tamiya,
and et al. 2022. "Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study" Journal of Clinical Medicine 11, no. 1: 116.
https://doi.org/10.3390/jcm11010116
APA Style
Inokuchi, R., Kuno, T., Komiyama, J., Uda, K., Miyamoto, Y., Taniguchi, Y., Abe, T., Ishimaru, M., Adomi, M., Tamiya, N., & Iwagami, M.
(2022). Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study. Journal of Clinical Medicine, 11(1), 116.
https://doi.org/10.3390/jcm11010116